Genzyme (GENZ) Reportedly Acquired by Sanofi-Aventis for $19.2B
Tweet Send to a Friend
Sanofi-Aventis SA reportedly has agreed to acquire Genzyme Corp. (NASDAQ: GENZ) for $19.2 billion in cash and future payments, according ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
